6
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Mefloquine-sulphadoxine-pyrimethamine (Fansimef®, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study

, , , , , , & show all
Pages 575-581 | Received 14 Jun 1991, Accepted 30 Jul 1992, Published online: 15 Nov 2016

REFERENCES

  • Bamber, M. G., Elder, A. T., Gray, J. A. & Minns, R. A. (1986). Fatal Stevens-Johnson syndrome asociated with Fansidar® and chloroquine. Journal of Infection, 13, 31–33.
  • Bernard, J., Lecamus, J., Sarrouy, J., Renard Dineau, J., Calami, G., Trifot, M. & Martin, D. (1987). Encephalopathie toxique a la mefloquine. Presse Medicale, 16, 1954–1955.
  • Harries, A. D. & Chugh, K. S. (1989). Chloroquine-induced pruritus in Nigerian medical and nursing students. Annals of Tropical Medicine and Parasitology, 80, 479–483.
  • Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Statistics, 6, 65–70.
  • Marcus, R., Peritz, E. & Gabriel, K. R. (1976). On closed testing procedures with special reference to ordered analysis of variance. Biometrika, 63, 655–660.
  • Miller, D. K., Lobel, H. O., Satriale, R. F., Kuritsky, J. N., Stern, R. & Campbell, C. C. (1986). Severe cutaneous reactions among American travellers using pyrimethamine-sulphadoxine (Fansidar®) for malaria prophylaxis. American Journal of Tropical Medicine and Hygiene, 35, 451–458.
  • Olsen, W., Loft, S. & Christensen, K. D. (1982). Serious reaction during malaria prophylaxis with pyrimethamine-sulphadoxine. Lancet, ii, 994.
  • Rouveix, B., Bricaire, F., Michon, C., Franssen, G., LeBras, J. & Bernard, J. (1989). Mefloquine and acute brain syndrome. Annals of Internal Medicine, 110, 577–578.
  • Sachs, L. (1984) Applied Statistics. New York: Springer Verlag.
  • Salako, L. A. (1984). Toxicity and side effects of antimalarials in Africa: a critical review. Bulletin of the World Health Organization, 62 (Suppl.), 63–68.
  • Salako, L. A. (1986). Malaria in Nigeria. In Proceedings of the Conference on Malaria in Africa, Washington, D.C., 1–4 December 1986, ed. Buck, A. A., pp. 131–141. Washington, D.C.: American Institute of Biological Sciences.
  • Salako, L. A., Aderounmu, A. F., Laoye, J. O., Makinde, J. M. & Adio, R. A. (1988). Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef®) in vivo and to mefloquine alone in vitro in Nigeria. Annals of Tropical Medicine and Parasitology, 82, 325–330.
  • Sowunmi, A., Salako, L. A., Walker, O. & Ogundahunsi, O. A. T. (1990). Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 761–764.
  • Sowunmi, A., Walker, O. & Salako, L. A. (1989). Pruritus and antimalarial drugs in Africans. Lancet, ii, 213.
  • Stuiver, P. C., Lighthelm, R. J. & Goud, T. J. L. M. (1989). Acute psychosis after mefloquine. Lancet, ii, 288.
  • World Health Organization (1984). Advances in Chemotherapy of Malaria. Technical Report Series No. 711. Geneva: WHO.
  • World Health Organization (1989). Central Nervous System Reactions Related to the Antimalarial Drug, Mefloquine. Mimeographed document WHO/89–1054. Geneva: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.